Lariba, Janeth .
HRN: 00-39-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2026
CEFUROXIME 1.5GM (VIAL)
08/17/2026
08/17/2026
IV
1.5 Gm
On Call To OR
Elective Open Cholecystectomy
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: